Neuropeptide Y2receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats
- 1 July 2006
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 148 (5) , 703-713
- https://doi.org/10.1038/sj.bjp.0706774
Abstract
The present study addressed the role of neuropeptide (NPY) Y2receptors in neurogenic contraction of mesenteric resistance arteries from female spontaneously hypertensive rats (SHR). Arteries were suspended in microvascular myographs, electrical field stimulation (EFS) was performed, and protein evaluated by Western blotting and immunohistochemistry. In vasopressin‐activated endothelium‐intact arteries, NPY and fragments with selectivity for Y1receptors, [Leu31,Pro34]NPY, Y2receptors, NPY(13–36), and rat pancreatic polypeptide evoked more pronounced contractions in segments from SHR than in Wistar Kyoto (WKY) arteries, even in the presence of the Y1receptor antagonist, BIBP3226 (0.3 μM, (R)‐N(2)‐(diphenacetyl)‐N‐[(4‐hydroxyphenyl)methyl]D‐arginineamide). In the presence of prazosin and during vasopressin activation, EFS‐evoked contractions were larger in arteries from SHR compared to WKY. EFS contractions were enhanced by the Y2receptor selective antagonist BIIE0246TF (0.5μM, (S)‐N2‐[[1‐[2‐[4‐[(R,S)‐5,11‐dihydro‐6(6h)‐oxodibenz[b,e]azepin‐11‐y1]‐1‐piperazinyl]‐2‐oxoethyl]cyclo‐pentyl‐N‐[2‐[1,2‐dihydro‐3,5 (4H)‐dioxo‐1,2‐diphenyl‐3H‐1,2,4‐triazol‐4‐yl]ethyl]‐argininamide), reduced by BIBP3226, and abolished by the combination of BIBP3226 and BIIE0246TF. Immunoblotting showed NPY Y1and Y2receptor expression to be similar in arteries from WKY and SHR, although a specific Y2receptor band at 80 kDa was detected only in arteries from WKY. Immunoreaction for NPY was enhanced in arteries from SHR. In contrast to arteries from WKY, BIIE0246TF increased NPY immunoreactivity in EFS‐stimulated arteries from SHR. The present results suggest that postjunctional neuropeptide Y1and Y2receptors contribute to neurogenic contraction of mesenteric small arteries. Moreover, both enhanced NPY content and altered neuropeptide Y1and Y2receptor activation apparently contribute to the enhanced neurogenic contraction of arteries from SHR. British Journal of Pharmacology(2006)148, 703–713. doi:10.1038/sj.bjp.0706774Keywords
This publication has 37 references indexed in Scilit:
- Pancreatic Polypeptide-Fold Peptide Receptors and Angiotensin II–Induced Renal VasoconstrictionHypertension, 2006
- Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteriesBritish Journal of Pharmacology, 2004
- Enhanced noradrenergic transmission in the spontaneously hypertensive rat anococcygeus muscleBritish Journal of Pharmacology, 2003
- The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptorsBritish Journal of Pharmacology, 2003
- Enhanced Neuropeptide Y Immunoreactivity and Vasoconstriction in Mesenteric Small Arteries from Spontaneously Hypertensive RatsJournal of Vascular Research, 2003
- Vascular pharmacology of BIIE0246, the first selective non‐peptide neuropeptide Y Y2 receptor antagonist, in vivoBritish Journal of Pharmacology, 2001
- Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctionsBritish Journal of Pharmacology, 2001
- Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y1‐receptor in rat mesenteric small arteriesBritish Journal of Pharmacology, 2000
- Impaired function of alpha-2 adrenoceptors in smooth muscle of mesenteric arteries from spontaneously hypertensive ratsBritish Journal of Pharmacology, 1998
- Characterization of Neuropeptide Y Receptors Mediating Contraction, Potentiation and Inhibition of RelaxationBlood Pressure, 1996